Home › Esophageal Cancer › Alaska › Anchorage
Esophageal Cancer clinical trials in Anchorage, AK
3 studies for Esophageal Cancer are looking for participants at sites in and around Anchorage (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- and 3 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Anchorage
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Alaska Oncology and Hematology, Anchorage
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Grand Rapids, MI14 studies
- Baldwin Park, CA14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Dallas, TX11 studies
Other studies in Anchorage
- Non-Small Cell Lung Cancer8 studies
- Ovarian Cancer7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Prostate Cancer4 studies
- Pancreatic Cancer4 studies
- Endometrial Cancer4 studies
- Stomach Cancer3 studies
- Cancer (all types)3 studies
- Acute Biphenotypic Leukemia3 studies
- Colorectal Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.